News

FDA Appointee Is a Notorious Drug Critic With a Lot to Prove
Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...
BioSpace5d
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
BioPharma Dive7d
Prasad’s FDA appointment pressures cell and gene therapy stocks
A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
STAT7d
Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...
FDA names Dr. Vinay Prasad as top vaccine official
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
BioPharma Dive5d
Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
Who Is Vinay Prasad? RFK Jr. Taps Pharma Critic to Lead FDA Vaccine Program
Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.
FDA taps critic of COVID policies, drug industry to lead vaccines division
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...
BioSpace7d
Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed Marks at CBER
The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and ...
Benzinga.com6d
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
FDA Commissioner Marty Makary on Tuesday named Vinay Prasad the next director ... controlled studies for new vaccine approvals. Prasad’s appointment at CBER will likely continue to pressure ...